N-terminal fragments of the proatrial natriuretic peptide in plasma and urine of kidney graft recipients

Transplantation

Volumn 72, Issue 1, 2001, Pages 89-94

  Franz, Martina ^a   Woloszczuk, Wolfgang ^b   Hörl, Walter H ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLOSPORIN; GLUCOCORTICOID;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; URINE;

ADULT; AGED; ATRIAL NATRIURETIC FACTOR; CREATININE; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; POSTOPERATIVE PERIOD; PROTEIN PRECURSORS; PROTEINURIA; REFERENCE VALUES;

EID: 0035879160     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200107150-00018     Document Type: Article

References (44)

1. Role of atrial natriuretic factor in volume control
2. The natriuretic peptide family
3. Structure of rat atrial natriuretic factor precursor deduced from cDNA sequence
4. Atrial natriuretic factor: Its (patho)physiological significance in humans
5. Synthesis and secretion of an atriopeptin-like protein in rat kidney cell culture
6. Two new hormones: Prohormone atrial natriuretic peptides 1-30 and 31-67 circulate in man
7. Atrial natriuretic hormones originating from the N-terminus of the atrial natriuretic factor prohormone
8. Urodilatin (ularitide, INN): A renal natriuretic peptide. Molecular biology and clinical importance
9. Regulation of natriuretic peptide (urodilatin) release in a human kidney cell line
10. Enzyme immunoassays for fragments (epitopes) of human proatrial natriuretic peptides
11. Identification and plasma concentrations of N-terminal fragment of proatrial natriuretic factor in man
12. Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure
13. Atrial natriuretic prohormone peptides 1-30, 31-67, and 79-98 vasodilate the aorta
14. Prohormone atrial natriuretic peptides 1-30, 31-67, and 99-126 increase in proportion to right ventricular pacing
15. Three peptides from the ANF prohormone NH2-terminus are natriuretic and/or kaliuretic
16. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left ventricular dysfunction
17. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction
18. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic peptides compared as early heart failure indicators
19. Change in plasma immunoreactive N-terminus, C-terminus, and 4.000-dalton midportion of atrial natriuretic factor prohormone with hemodialysis
20. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment
21. Atrial natriuretic factor and liver disease
22. Normalization of circulating atrial natriuretic peptides in cardiac transplant recipients
23. Normalization of elevated circulating N-terminal and C-terminal atrial natriuretic factor prohormone concentrations by renal transplantation
24. Atrial natriuretic peptide fragments in dogs with experimental heart failure
25. Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans
26. Modulation of renin secretion by atrial natriuretic factor prohormone fragment 31-67
27. Is urodilatin (rather than atriopeptin) the primary natriuretic peptide of the ANP family?
28. Atrial natriuretic peptide release and volume regulation following kidney transplantation
29. Glucocorticoid and mineralocorticoid stimulation of atrial natriuretic peptide release in man
30. The secretion of atrial natriuretic factor-(99-126) by cultured cardiac myocytes is regulated by glucocorticoids
31. Ventricular atriopeptin: Unmasking of messenger RNA and peptide synthesis by hypertrophy or dexamethasone
32. Gene for the rat atrial natriuretic peptide is regulated by glucocorticoids in vitro
33. Atrial natriuretic peptide mRNA is regulated by glucocorticoids in vivo
34. Structure-activity relationship of atrial natriuretic factor (ANF). II. Effect of chain-length modifications on vascular reactivity
35. The sodium-retaining effects of cyclosporine
36. The beneficial effect of atrial natriuretic peptide on cyclosporine nephrotoxicity
37. Cellular signaling by cyclosporine A in contractile cells: Interactions with atrial natriuretic peptide
38. Twenty-four hour pattern of atrial natriuretic peptide in heart transplantation: Evidence for lack of circadian rhythm. Temporal inter-ralationships with plasma renin activity, aldosterone and cortisol
39. Fluid homeostasis after heart transplantation: The role of cardiac denervation
40. Calorie-restricted weight reduction, blood pressure, and atrial natriuretic peptides
41. Long-term hemodynamic follow-up of cardiac transplant patients treated with cyclosporine and prednisone
42. Cyclosporine A impairs the nocturnal blood pressure fall in renal transplant recipients
43. Plasma atrial natriuretic factor and graft function in renal transplant recipients